Drug profile · INN
pertussis vaccine (recombinant, acellular, component, adsorbed)
VACPERTAGEN
pertussis vaccine (recombinant, acellular, component, adsorbed) (VACPERTAGEN) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antiinfectives for systemic use (J07) J07AJ02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — pertussis vaccine (recombinant, acellular, component, adsorbed)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
pertussis vaccine (recombinant, acellular, component, adsorbed) (VACPERTAGEN) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN pertussis vaccine (recombinant, acellular, component, adsorbed)
Brand VACPERTAGEN
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07AJ02
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pertussis vaccine (recombinant, acellular, component, adsorbed)?
pertussis vaccine (recombinant, acellular, component, adsorbed) (VACPERTAGEN) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for pertussis vaccine (recombinant, acellular, component, adsorbed)?
VACPERTAGEN is a marketed brand name for pertussis vaccine (recombinant, acellular, component, adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.